A Randomized Double-Blind Controlled Study of CS-8958 Versus Oseltamivir Phosphate in Patients With Influenza Virus Infection.
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2011
At a glance
- Drugs Laninamivir; Oseltamivir
- Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
- Focus Registrational; Therapeutic Use
- Acronyms MARVEL
- Sponsors Daiichi Sankyo Company
- 11 Oct 2010 Results published in Clinical Infectious Diseases.
- 10 Aug 2009 Top-line results reported in a Daiichi Sankyo Company media release.
- 10 Aug 2009 Data from this trial will be used in the NDA submission to the US FDA, according to a Daiichi Sankyo Company media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History